TY - JOUR
T1 - Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave – a nationwide study in Japan
AU - Tanaka, Hiromu
AU - Chubachi, Shotaro
AU - Asakura, Takanori
AU - Namkoong, Ho
AU - Azekawa, Shuhei
AU - Otake, Shiro
AU - Nakagawara, Kensuke
AU - Fukushima, Takahiro
AU - Lee, Ho
AU - Watase, Mayuko
AU - Sakurai, Kaori
AU - Kusumoto, Tatsuya
AU - Masaki, Katsunori
AU - Kamata, Hirofumi
AU - Ishii, Makoto
AU - Hasegawa, Naoki
AU - Okada, Yukinori
AU - Koike, Ryuji
AU - Kitagawa, Yuko
AU - Kimura, Akinori
AU - Imoto, Seiya
AU - Miyano, Satoru
AU - Ogawa, Seishi
AU - Kanai, Takanori
AU - Fukunaga, Koichi
N1 - Funding Information:
This work was supported by the Japan Agency for Medical Research and Development (AMED) (grant numbers JP20nk0101612, JP20fk0108415, JP21jk0210034, JP21km0405211, JP21km0405217, JP21wm0325031, JP21fk0108573); Japan Science and Technology Agency (JST) CREST (grant number JPMJCR20H2); JST PRESTO (grant number JPMJPR21R7); and the Ministry of Health, Labour, and Welfare (grant number 20CA2054). This study was approved by the ethics committee of the Keio University School of Medicine (20200061) and related research institutions. All participants provided informed consent. We would like to thank all participants involved in this study and all members of the Japan COVID-19 Task Force regularly engaged in clinical and research work on COVID-19. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Funding Information:
This work was supported by the Japan Agency for Medical Research and Development (AMED) (grant numbers JP20nk0101612, JP20fk0108415, JP21jk0210034, JP21km0405211, JP21km0405217, JP21wm0325031, JP21fk0108573); Japan Science and Technology Agency (JST) CREST (grant number JPMJCR20H2); JST PRESTO (grant number JPMJPR21R7); and the Ministry of Health, Labour, and Welfare (grant number 20CA2054).
Publisher Copyright:
© 2023 The Authors
PY - 2023/7
Y1 - 2023/7
N2 - Objectives: COVID-19 was severe in the Delta variant-dominated epidemic wave (fifth wave) in Japan. The clinical characteristics and effectiveness of COVID-19 vaccination are not fully understood in the Omicron variant-dominated wave (sixth and seventh waves), especially in hospitalized patients. We investigated the relationship between vaccination and disease severity in the Omicron-dominated wave and compared these variant-dominated waves. Methods: The nationwide COVID-19 database (Japan COVID-19 Task Force) was used to compare clinical characteristics and critical outcomes in patients hospitalized with Delta (fifth, N = 735) vs Omicron-dominated waves (sixth, N = 495; seventh, N = 128). Results: Patients in the sixth and seventh waves had a lower incidence of critical outcomes and respiratory outcomes, and a higher incidence of bacterial infection, although the mortality rate did not differ significantly between waves. In the sixth and seventh waves, 138 (27.9%) and 29 (22.7%) patients with COVID-19 were unvaccinated, respectively. Multivariable analysis adjusted with previously reported factors revealed that the proportion of (1) critical outcomes and (2) respiratory outcomes decreased in a frequency-dependent manner. Thus, (1) (the number of vaccinations): 1-2 times: adjusted odds ratio (aOR) 0.37 (95% confidence interval [CI]; 0.20-0.69); 3-4 times: aOR 0.25 (95% CI; 0.11-0.58); and (2) 1-2 times: aOR 0.43 (95% CI; 0.27-0.66); 3-4 times: aOR 0.36 (95% CI; 0.21-0.60). Conclusions: Patients hospitalized with COVID-19 with Omicron infections showed a lower incidence of critical outcomes than those with Delta infections, and COVID-19 vaccination may contribute to preventing respiratory failure.
AB - Objectives: COVID-19 was severe in the Delta variant-dominated epidemic wave (fifth wave) in Japan. The clinical characteristics and effectiveness of COVID-19 vaccination are not fully understood in the Omicron variant-dominated wave (sixth and seventh waves), especially in hospitalized patients. We investigated the relationship between vaccination and disease severity in the Omicron-dominated wave and compared these variant-dominated waves. Methods: The nationwide COVID-19 database (Japan COVID-19 Task Force) was used to compare clinical characteristics and critical outcomes in patients hospitalized with Delta (fifth, N = 735) vs Omicron-dominated waves (sixth, N = 495; seventh, N = 128). Results: Patients in the sixth and seventh waves had a lower incidence of critical outcomes and respiratory outcomes, and a higher incidence of bacterial infection, although the mortality rate did not differ significantly between waves. In the sixth and seventh waves, 138 (27.9%) and 29 (22.7%) patients with COVID-19 were unvaccinated, respectively. Multivariable analysis adjusted with previously reported factors revealed that the proportion of (1) critical outcomes and (2) respiratory outcomes decreased in a frequency-dependent manner. Thus, (1) (the number of vaccinations): 1-2 times: adjusted odds ratio (aOR) 0.37 (95% confidence interval [CI]; 0.20-0.69); 3-4 times: aOR 0.25 (95% CI; 0.11-0.58); and (2) 1-2 times: aOR 0.43 (95% CI; 0.27-0.66); 3-4 times: aOR 0.36 (95% CI; 0.21-0.60). Conclusions: Patients hospitalized with COVID-19 with Omicron infections showed a lower incidence of critical outcomes than those with Delta infections, and COVID-19 vaccination may contribute to preventing respiratory failure.
KW - Delta
KW - Disease outbreaks
KW - Immunization
KW - Inpatients
KW - Omicron
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85156123652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85156123652&partnerID=8YFLogxK
U2 - 10.1016/j.ijid.2023.04.399
DO - 10.1016/j.ijid.2023.04.399
M3 - Article
C2 - 37086866
AN - SCOPUS:85156123652
SN - 1201-9712
VL - 132
SP - 84
EP - 88
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
ER -